Tuesday, 21 December, 2021
CeNS welcomes a new member!
Dr. David Konrad studied chemistry and biochemistry at the Ludwig Maximilian University (LMU) Munich and received his M.Sc. in 2013. During Master's studies, he worked as a visiting researcher in the group of Dean Toste at the University of California, Berkeley and the group of Benjamin List at the Max Planck Institute for Coal Research in Mülheim a. d. Ruhr. In 2014, David joined the group of Dirk Trauner for his graduate studies to work towards an asymmetric synthesis of tetrodotoxin and methods to red-shift photopharmaceuticals. After graduating in 2018, David moved to the Scripps Research Institute in La Jolla as a postdoctoral fellow under the guidance of Benjamin Cravatt. As part of the return phase of his fellowship, David joined the group of Ivan Huc at the Department of Pharmacy of the LMU Munich, where he became a group leader funded by a Liebig fellowship in 2021. His research interests include:
- Redshifted Photoswitchable Nanoagents
- Synthetic Methodologies
- Drug Development
- Chemical Proteomics
- Non-Small Cell Lung Cancer